Kingworld Medicines Group Limited (HKG:1110)

Kingworld Medicines Group Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	178.56	264.41	235.3	173.68	242.16	187.93
Trading Asset Securities	9.83	10.18	14.3	20.35	14.01	10.48
Cash & Short-Term Investments	188.38	274.59	249.6	194.03	256.17	198.41
Cash Growth	-26.08%	10.01%	28.64%	-24.26%	29.11%	-24.12%
Accounts Receivable	120.21	157.43	157.72	152.53	183.18	237.83
Other Receivables	-	10.16	39.72	79.21	48.61	37.89
Receivables	120.21	167.6	202.84	236.49	236.64	280.1
Inventory	119.69	133.29	120.22	117.63	84.76	106.74
Other Current Assets	45.11	38.27	35.11	40.47	46.75	54.41
Total Current Assets	473.39	613.74	607.77	588.62	624.32	639.66
Property, Plant & Equipment	446.62	449.8	423.71	385.72	299.89	209.94
Long-Term Investments	160.26	161.7	167.37	152.01	133.82	138.04
Goodwill	90.69	90.69	90.69	90.69	90.69	90.69
Other Intangible Assets	-	-	-	-	0.13	13.7
Other Long-Term Assets	130.57	126.46	126.03	120.62	114.5	121.8
Total Assets	1,302	1,442	1,416	1,338	1,263	1,214

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	43.9	169.98	168.32	148.66	138.79	106.1
Accrued Expenses	69.21	39.32	42.55	38	7.46	10.87
Current Portion of Long-Term Debt	260.57	265.01	225.66	191.66	271.29	229.92
Current Portion of Leases	7.5	6.8	4.36	6.37	8.01	7.58
Current Income Taxes Payable	5.77	7.37	10.86	15.38	16.51	11.9
Current Unearned Revenue	64.82	66.4	59.93	57.17	57.54	71.73
Other Current Liabilities	-	10.42	3.19	6.29	42.16	35.52
Total Current Liabilities	451.77	565.3	514.87	463.53	541.74	473.62
Long-Term Debt	160.25	149.38	161.95	150.47	-	-
Long-Term Leases	9.81	12.68	10.47	5.93	11.39	1.45
Long-Term Unearned Revenue	-	-	-	-	0.6	-
Long-Term Deferred Tax Liabilities	27.21	26.18	22.75	18.37	15.42	18.12
Total Liabilities	649.04	753.54	710.04	638.3	569.15	493.2

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	53.47	53.47	53.47	53.47	53.47	53.47
Additional Paid-In Capital	-	139.41	139.41	139.41	139.41	152.7
Retained Earnings	-	505.61	512.26	490.49	466.31	443.57
Comprehensive Income & Other	543.09	-80.78	-65.35	-64.33	-43.61	-32.84
Total Common Equity	596.56	617.7	639.79	619.03	615.58	616.9
Minority Interest	55.94	71.15	65.74	80.32	78.64	103.74
Shareholders' Equity	652.5	688.85	705.53	699.35	694.22	720.63
Total Liabilities & Equity	1,302	1,442	1,416	1,338	1,263	1,214

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	438.13	433.87	402.44	354.43	290.68	238.96
Net Cash (Debt)	-249.74	-159.28	-152.84	-160.4	-34.51	-40.55
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.42	-0.27	-0.27	-0.27	-0.06	-0.07
Filing Date Shares Outstanding	583.35	592.46	589.6	592.45	622.5	622.5
Total Common Shares Outstanding	583.35	592.46	589.6	592.45	622.5	622.5
Working Capital	21.62	48.44	92.9	125.08	82.58	166.03
Book Value Per Share	1.02	1.04	1.09	1.04	0.99	0.99
Tangible Book Value	505.87	527.01	549.1	528.34	524.75	512.5
Tangible Book Value Per Share	0.87	0.89	0.93	0.89	0.84	0.82
Land	-	21.25	15.81	15.22	7.55	6.98
Buildings	-	195.58	271.9	24.26	24.26	24.26
Machinery	-	97.67	95.81	93.84	89.36	78.61
Construction In Progress	-	96.18	0.6	204.11	116.33	36.15
Leasehold Improvements	-	34.01	21.43	20.88	20.66	18.37

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 13, 2026

Data Sources Report a data error